Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeuroPace Inc.

12.23
-0.7800-6.00%
Post-market: 12.230.00000.00%17:47 EDT
Volume:221.31K
Turnover:2.69M
Market Cap:398.21M
PE:-13.12
High:12.68
Open:12.40
Low:11.83
Close:13.01
Loading ...

Company Profile

Company Name:
NeuroPace Inc.
Exchange:
NASDAQ
Establishment Date:
1997
Employees:
184
Office Location:
455 North Bernardo Avenue,Mountain View,California,United States
Zip Code:
94043
Fax:
(650) 237-2701
Introduction:
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. The company's RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip leads and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Directors

Name
Position
Michael Favet
Director, President and Chief Executive Officer
Evan Norton
Director
Frank Fischer
Director
Greg Garfield
Director
Joseph Lacob
Director
Nael Karim Kassar
Director
Rakhi Kumar
Director
Renee Ryan
Director
Rishi Gupta
Director

Shareholders

Name
Position
Michael Favet
Director, President and Chief Executive Officer
Rebecca Kuhn
Chief Financial Officer and Vice President, Finance and Administration
Irina Ridley
General Counsel and Corporate Secretary
Martha Morrell
Chief Medical Officer